Literature DB >> 10970357

Molecular characterization of Mycobacterium tuberculosis H37Rv/Ra variants: distinguishing the mycobacterial laboratory strain.

P Bifani1, S Moghazeh, B Shopsin, J Driscoll, A Ravikovitch, B N Kreiswirth.   

Abstract

The Mycobacterium tuberculosis strains H37Rv and H37Ra are the most commonly used controls for M. tuberculosis identification in the clinical and research laboratory setting. To reduce the likelihood of misidentification and possible cross-contamination with this laboratory neotype, it is important to be able to distinguish H37 from clinical isolates. To provide a reference for identifying H37, we used multiple molecular techniques to characterize H37 strains, including 18 of the most frequently used variants available through the American Type Culture Collection. Isolates were genotyped using gene probes to IS6110 and IS1085. In addition, we performed polymorphic GC-rich sequence typing (PGRS), spoligotyping, determination of variable number of tandem repeats (VNTR), and PCR amplification of the mtp40, msx4, and mpp8 polymorphic regions. Southern hybridization with IS6110 provided the most discrimination, differentiating the 18 H37 isolates into 10 discrete patterns made up of 9 H37Rv variants and 1 H37Ra variant. PGRS, IS1085, mpp8, and spoligotyping were not able to distinguish any H37 variants, while VNTR and msx4 discriminated two. Only IS6110 and spoligotyping could distinguish the H37 strain from clinical isolates. In summary, spoligotyping and IS6110 provide a rapid and accurate way to identify H37 contamination, though IS6110 can, in addition, classify many of the H37 variants that would otherwise require phenotypic segregation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10970357      PMCID: PMC87354     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  The antituberculous activity of thioamide in vitro and in the experimental animal (mouse and guinea pig).

Authors:  W STEENKEN; V MONTALBINE
Journal:  Am Rev Respir Dis       Date:  1960-05

2.  Further observations of pyrazinamide alone and in combination with other drugs in experimental tuberculosis.

Authors:  W STEENKEN; E WOLINSKY; M M SMITH; V MONTALBINE
Journal:  Am Rev Tuberc       Date:  1957-10

3.  Antituberculous activity of hinconstarch, a synthetic polymer of isoniazid, amithiozone, and starch.

Authors:  E WOLINSKY; W STEENKEN
Journal:  Am Rev Tuberc       Date:  1956-01

4.  Restriction fragment length polymorphism study of Mycobacterium tuberculosis in Thailand using IS6110 as probe.

Authors:  P Palittapongarnpim; P Luangsook; S Tansuphaswadikul; C Chuchottaworn; R Prachaktam; B Sathapatayavongs
Journal:  Int J Tuberc Lung Dis       Date:  1997-08       Impact factor: 2.373

5.  False-positive results from cultures of Mycobacterium tuberculosis due to laboratory cross-contamination confirmed by restriction fragment length polymorphism.

Authors:  J Bauer; V O Thomsen; S Poulsen; A B Andersen
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures.

Authors:  P M Small; N B McClenny; S P Singh; G K Schoolnik; L S Tompkins; P A Mickelsen
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.

Authors:  P Del Portillo; L A Murillo; M E Patarroyo
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis.

Authors:  D van Soolingen; P E de Haas; P W Hermans; P M Groenen; J D van Embden
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting.

Authors:  J M Van Duin; J E Pijnenburg; C M van Rijswoud; P E de Haas; W D Hendriks; D van Soolingen
Journal:  Int J Tuberc Lung Dis       Date:  1998-05       Impact factor: 2.373

10.  BIOLOGICAL STUDIES OF THE TUBERCLE BACILLUS : III. DISSOCIATION AND PATHOGENICITY OF THE R AND S VARIANTS OF THE HUMAN TUBERCLE BACILLUS (H(37)).

Authors:  W Steenken; W H Oatway; S A Petroff
Journal:  J Exp Med       Date:  1934-09-30       Impact factor: 14.307

View more
  16 in total

1.  The value of comparative genomics in understanding mycobacterial virulence: Mycobacterium tuberculosis H37Ra genome sequencing - a worthwhile endeavour.

Authors:  Deepak Sharma; Jaya Sivaswami Tyagi
Journal:  J Biosci       Date:  2007-03       Impact factor: 1.826

2.  Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

Authors:  Thomas R Ioerger; Yicheng Feng; Krishna Ganesula; Xiaohua Chen; Karen M Dobos; Sarah Fortune; William R Jacobs; Valerie Mizrahi; Tanya Parish; Eric Rubin; Chris Sassetti; James C Sacchettini
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

Review 3.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  1,4-Benzoquinone antimicrobial agents against Staphylococcus aureus and Mycobacterium tuberculosis derived from scorpion venom.

Authors:  Edson Norberto Carcamo-Noriega; Shyam Sathyamoorthi; Shibdas Banerjee; Elumalai Gnanamani; Monserrat Mendoza-Trujillo; Dulce Mata-Espinosa; Rogelio Hernández-Pando; José Ignacio Veytia-Bucheli; Lourival D Possani; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

5.  Localization of Cyclopropane Modifications in Bacterial Lipids via 213 nm Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Molly S Blevins; Dustin R Klein; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2019-05-03       Impact factor: 6.986

6.  Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.

Authors:  Vanessa Mathys; René Wintjens; Philippe Lefevre; Julie Bertout; Amit Singhal; Mehdi Kiass; Natalia Kurepina; Xiao-Ming Wang; Barun Mathema; Alain Baulard; Barry N Kreiswirth; Pablo Bifani
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

7.  Genotype analysis of Mycobacterium tuberculosis isolates from a sentinel surveillance population.

Authors:  Lauren S Cowan; Jack T Crawford
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

8.  Simple and rapid differentiation of Mycobacterium tuberculosis H37Ra from M. tuberculosis clinical isolates through two cytochemical tests using neutral red and nile blue stains.

Authors:  Carlos Y Soto; Núria Andreu; Isidre Gibert; Marina Luquin
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv.

Authors:  Richard F Silver; Jessica Walrath; Hung Lee; Bruce A Jacobson; Heidi Horton; Michael R Bowman; Karl Nocka; Joseph P Sypek
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

10.  Characterization of a trinucleotide repeat sequence (CGG)5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis.

Authors:  Yayoi Otsuka; Pawel Parniewski; Zofia Zwolska; Masatake Kai; Tomoko Fujino; Fumiko Kirikae; Emiko Toyota; Koichiro Kudo; Tadatoshi Kuratsuji; Teruo Kirikae
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.